TY - JOUR
T1 - Malaria in travelers
T2 - A review of the GeoSentinel surveillance network
AU - Leder, Karin
AU - Black, Jim
AU - O'Brien, Dan
AU - Greenwood, Zoe
AU - Kain, Kevin C.
AU - Schwartz, Eli
AU - Brown, Graham
AU - Torresi, Joseph
PY - 2004/10/15
Y1 - 2004/10/15
N2 - Background. Malaria is a common and important infection in travelers. Methods. We have examined data reported to the GeoSentinel surveillance network to highlight characteristics of malaria in travelers. Results. A total of 1140 malaria cases were reported (60% of cases were due to Plasmodium falciparum, 24% were due to Plasmodium vivax). Male subjects constituted 69% of the study population. The median duration of travel was 34 days; however, 37% of subjects had a travel duration of ≤4 weeks. The majority of travellers did not have a pretravel encounter with a health care provider. Most cases occurred in travelers (39%) or immigrants/ refugees (38%). The most common reasons for travel were to visit friends/relatives (35%) or for tourism (26%). Three-quarters of infections were acquired in sub-Saharan Africa. Severe and/or complicated malaria occurred in 33 cases, with 3 deaths. Compared with others in the GeoSentinel database, patients with malaria had traveled to sub-Saharan Africa more often, were more commonly visiting friends/relatives, had traveled for longer periods, presented sooner after return, were more likely to have a fever at presentation, and were less likely to have had a pretravel encounter. In contrast to immigrants and visitors of friends or relatives, a higher proportion (73%) of the missionary/volunteer group who developed malaria had a pretravel encounter with a health care provider. Travel to sub-Saharan Africa and Oceania was associated with the greatest relative risk of acquiring malaria. Conclusions. We have used a global database to identify patient and travel characteristics associated with malaria acquisition and characterized differences in patient type, destinations visited, travel duration, and malaria species acquired.
AB - Background. Malaria is a common and important infection in travelers. Methods. We have examined data reported to the GeoSentinel surveillance network to highlight characteristics of malaria in travelers. Results. A total of 1140 malaria cases were reported (60% of cases were due to Plasmodium falciparum, 24% were due to Plasmodium vivax). Male subjects constituted 69% of the study population. The median duration of travel was 34 days; however, 37% of subjects had a travel duration of ≤4 weeks. The majority of travellers did not have a pretravel encounter with a health care provider. Most cases occurred in travelers (39%) or immigrants/ refugees (38%). The most common reasons for travel were to visit friends/relatives (35%) or for tourism (26%). Three-quarters of infections were acquired in sub-Saharan Africa. Severe and/or complicated malaria occurred in 33 cases, with 3 deaths. Compared with others in the GeoSentinel database, patients with malaria had traveled to sub-Saharan Africa more often, were more commonly visiting friends/relatives, had traveled for longer periods, presented sooner after return, were more likely to have a fever at presentation, and were less likely to have had a pretravel encounter. In contrast to immigrants and visitors of friends or relatives, a higher proportion (73%) of the missionary/volunteer group who developed malaria had a pretravel encounter with a health care provider. Travel to sub-Saharan Africa and Oceania was associated with the greatest relative risk of acquiring malaria. Conclusions. We have used a global database to identify patient and travel characteristics associated with malaria acquisition and characterized differences in patient type, destinations visited, travel duration, and malaria species acquired.
UR - http://www.scopus.com/inward/record.url?scp=12844266761&partnerID=8YFLogxK
U2 - 10.1086/424510
DO - 10.1086/424510
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 15486832
AN - SCOPUS:12844266761
SN - 1058-4838
VL - 39
SP - 1104
EP - 1112
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 8
ER -